Another Ranbaxy Mystery: What Happened To Valsartan?
This article was originally published in The Pink Sheet Daily
Executive Summary
Ranbaxy’s valsartan application may have been held back after FDA detected lapses at the company’s new manufacturing site in Mohali, India, according to sources, but the beleaguered company has a plan to move forward.